Compare
Vontier Corp vs Teradyne, Inc vs Revvity, Inc. vs Bruker Corp
| Latest fiscal year | Vontier Corp VNT | Teradyne, Inc TER | Revvity, Inc. RVTY | Bruker Corp BRKR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-28 | 2025-12-31 |
| Revenue | $3.08B | $3.19B | $2.86B | $3.44B |
| Revenue growth (YoY) | +3.2% | +13.1% | +3.7% | +2.1% |
| Gross margin | n/a | 58.2% | n/a | 45.9% |
| Operating margin | 18.3% | 20.4% | 12.5% | 2.0% |
| Net margin | 13.2% | 17.4% | 8.4% | -0.2% |
| Net income | $406.10M | $554.05M | $241.20M | -$8.30M |
| EPS (Diluted) | $2.76 | $3.47 | $2.07 | -$0.15 |
| Operating cash flow | $511.00M | $674.41M | $582.93M | $134.10M |
| Free cash flow | $441.10M | $450.41M | $509.41M | $43.30M |
| Cash & equivalents | $492.20M | $293.75M | $919.86M | $298.80M |
| Total assets | $4.37B | $4.18B | $12.17B | $6.24B |
| Total liabilities | $3.12B | $1.39B | $4.92B | $3.73B |
| Shareholders' equity | $1.25B | $2.80B | $7.25B | $2.47B |
| Return on year-end equity | 32.5% | 19.8% | 3.3% | -0.3% |
| Shares outstanding | 142.20M | 156.09M | 112.28M | 152.14M |
Revenue, most recent five fiscal years
| Fiscal year | Vontier Corp | Teradyne, Inc | Revvity, Inc. | Bruker Corp |
|---|---|---|---|---|
| Latest | $3.08B Ended 2025-12-31 | $3.19B Ended 2025-12-31 | $2.86B Ended 2025-12-28 | $3.44B Ended 2025-12-31 |
| 1 year earlier | $2.98B Ended 2024-12-31 | $2.82B Ended 2024-12-31 | $2.76B Ended 2024-12-29 | $3.37B Ended 2024-12-31 |
| 2 years earlier | $3.10B Ended 2023-12-31 | $2.68B Ended 2023-12-31 | $2.75B Ended 2023-12-31 | $2.96B Ended 2023-12-31 |
| 3 years earlier | $3.18B Ended 2022-12-31 | $3.16B Ended 2022-12-31 | $3.31B Ended 2023-01-01 | $2.53B Ended 2022-12-31 |
| 4 years earlier | $2.99B Ended 2021-12-31 | $3.70B Ended 2021-12-31 | $3.83B Ended 2022-01-02 | $2.42B Ended 2021-12-31 |